Ovarian suppression with tamoxifen

However, for women who were at sufficient risk for recurrence to warrant We conclude that for premenopausal women with hormone-receptor–positive breast cancer, adjuvant treatment with ovarian suppression plus the aromatase inhibitor exemestane, as compared to ovarian suppression plus tamoxifen, provides a new treatment option that reduces the risk of recurrence. Blocking estrogen production: Drugs called aromatase inhibitors are used to block the activity of an enzyme called aromatase, which the body uses to make estrogen in the ovaries and in other tissues

2024-03-28
    Finca buenavista el palmar
  1. Hormone therapy Goserelin
  2. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women
  3. 03)